Sarcoma: all 1,691 studies
Page 12 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.
- Response Based Treatment for Children With Unresectable Localized Soft Tissue SarcomaStatus unknownNCT02784015Phase 2
- National Swiss Sarcoma Cohort StudyTerminatedNCT02775799
- A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory MedulloblastomaCompletedNCT02748135Phase 1
- Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's SarcomaCompletedNCT02736565Phase 1
- Protocol for the Treatment of Metastatic Ewing SarcomaCompletedNCT02727387Phase 2
- Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent SarcomaTerminatedNCT02720796Not applicable
- Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordActive, not recruitingNCT02713269Phase 2
- SARC021C: A Continuation Study of TH-CR-406/SARC021No longer availableNCT02712567
- Stereotactic Radiosurgery for Soft Tissue SarcomaWithdrawnNCT02706171Not applicable
- Advanced MR Imaging in Sarcoma PatientsCompletedNCT02705391
- DHEA in Synovial Sarcoma PatientsTerminatedNCT02683148Phase 1
- Trial Comparing Trabectedin to the Best Supportive Care in Patients With SarcomaCompletedNCT02672527Phase 3
- Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsActive, not recruitingNCT02650401Phase 1/2
- A Study of LY2880070 in Participants With Advanced or Metastatic CancerCompletedNCT02632448Phase 1/2
- A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)Status unknownNCT02630368Phase 1/2
- Safety Study of MGD009 in B7-H3-expressing TumorsTerminatedNCT02628535Phase 1
- A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in GreeceCompletedNCT02618122
- Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsCompletedNCT02611024Phase 1/2
- Quantitative Imaging Biomarkers for SarcomaCompletedNCT02579980Not applicable
- A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsCompletedNCT02576431Phase 2
- Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma PatientsTerminatedNCT02575066Phase 2
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
- A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated LiposarcomaStatus unknownNCT02571829Phase 2
- Compassionate Use of Aldoxorubicin in Sarcoma Patients ChemotherapyNo longer availableNCT02570412
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
- ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsCompletedNCT02565758Phase 1
- Preoperative vs Postoperative IMRT for Extremity/Truncal STSActive, not recruitingNCT02565498Phase 3
- SBRT Treatment for Lung Metastasis From Soft Tissue SarcomaStatus unknownNCT02561559
- HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid TumorsWithdrawnNCT02557854Phase 1
- Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues (SkinAge).CompletedNCT02553954Not applicable
- Genetic and Telomere Characteristics of High of Grade Soft Tissue SarcomasTerminatedNCT02547376
- A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid TumorsTerminatedNCT02536183Phase 1
- Outcomes in Lower Extremity Soft Tissue Sarcoma Patients After Limb SalvageCompletedNCT02536053
- A Study of IMRT in Primary Bone and Soft Tissue SarcomaCompletedNCT02520128Not applicable
- Trabectedin and Irinotecan for Refractory Pediatric SarcomasStatus unknownNCT02509234
- Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or SarcomaWithdrawnNCT02507076Not applicable
- Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young AdultsCompletedNCT02496520Phase 1/2
- Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings SarcomaCompletedNCT02472392Phase 1
- Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing SurgeryWithdrawnNCT02464332Phase 1
- Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)Status unknownNCT02449343Phase 2/3
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing DoxorubicinCompletedNCT02423356
- Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue SarcomasCompletedNCT02415816Not applicable
- Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GISTActive, not recruitingNCT02413736Phase 3
- Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for SarcomasStatus unknownNCT02409576Phase 1/2
- Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)CompletedNCT02398058Phase 1
- Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsCompletedNCT02390843Phase 1
- Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue SarcomaCompletedNCT02384473Early Phase 1
- NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk WallCompletedNCT02379845Phase 2/3
- Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue SarcomaCompletedNCT02367924
- Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue SarcomaWithdrawnNCT02367651Phase 2
- Hyper-Thermia Enhanced Anti-tumor Efficacy of TrabectedinStatus unknownNCT02359474Phase 2
- Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective StudyStatus unknownNCT02309242Not applicable
- PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot StudyActive, not recruitingNCT02307630Not applicable
- Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerActive, not recruitingNCT02298959Phase 1
- Evaluating Bacterial Response in Sarcoma Management Using Fluorescence ImagingCompletedNCT02270086
- Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi SarcomaWithdrawnNCT02229981Phase 1/2
- Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s SarcomaStatus unknownNCT02212639Phase 2
- Adoptive Therapy Using Antigen-Specific CD4 T-CellsWithdrawnNCT02210104Phase 1
- Patient Directed Intervention to Improve the Quality of Life for Patients With Soft Tissue SarcomaCompletedNCT02204111
- Identification and Characterization of Molecular Markers in Musculoskeletal TumorsTerminatedNCT02199938
- α-TEA in Advanced CancerCompletedNCT02192346Phase 1
- Survivorship Care in Reducing Symptoms in Young Adult Cancer SurvivorsCompletedNCT02192333Not applicable
- TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02180698Phase 1
- Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi SarcomaWithdrawnNCT02137564Phase 2
- Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue SarcomasStatus unknownNCT02120768Phase 3
- Pazopanib for Metastatic Alveolar Soft Part SarcomaTerminatedNCT02113826Phase 2
- Validation of MMS Test for Cancer MonitoringTerminatedNCT02113683
- A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid TumorsCompletedNCT02107963Phase 1
- Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung DiseaseCompletedNCT02080897
- Nelfinavir for the Treatment of Gammaherpesvirus-Related TumorsTerminatedNCT02080416Early Phase 1
- MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid TumorsCompletedNCT02076906Phase 1
- L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid TumoursCompletedNCT02076620Phase 1
- Ensuring Communication in Hospice by Oncology Study (ECHO)CompletedNCT02069769Not applicable
- Efficacy of Dose Intensification in Patients With Non-metastatic Ewing SarcomaCompletedNCT02063022Phase 3
- NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell LiposarcomaWithdrawnNCT02059850Phase 1
- PP-Gemcitabine & External Beam Radiation-SarcomasCompletedNCT02046304Phase 1
- ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing SarcomaCompletedNCT02044120Phase 1
- A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and TreatmentCompletedNCT02041689
- Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?TerminatedNCT02022358Phase 2
- A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerCompletedNCT02015416Phase 1
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsCompletedNCT02014337Phase 1
- Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STSCompletedNCT01995981
- Combined Modality Treatment of Sarcomas of the ExtremitiesCompletedNCT01985295Phase 1
- A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing SarcomaWithdrawnNCT01969942Phase 1
- MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS StudyCompletedNCT01956019Not applicable
- Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional ChemotherapySuspendedNCT01921998
- PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-DerivativeCompletedNCT01916135Phase 1
- Hyperthermia and Proton Therapy in Unresectable Soft Tissue SarcomaStatus unknownNCT01904565Phase 1/2
- Preoperative Imaging in Retroperitoneal SarcomaCompletedNCT01902667
- Phase II Study of Regorafenib in Metastatic Soft Tissue SarcomaCompletedNCT01900743Phase 2
- Definitive Therapy for Oligometastatic Solid MalignanciesStatus unknownNCT01898962Phase 2
- Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerCompletedNCT01896778Not applicable
- Autologous Dendritic Cell Vaccine in Patients With Soft Tissue SarcomaStatus unknownNCT01883518Phase 1/2
- Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing SarcomaTerminatedNCT01882231Not applicable
- Genetic Biomarkers in Saliva Samples From Patients With Ewing SarcomaCompletedNCT01876303
- NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid TumorsCompletedNCT01875601Phase 1
- A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue SarcomaCompletedNCT01861951Phase 2
- RAD001 in Advanced SarcomaCompletedNCT01830153Phase 2
- 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing SarcomaCompletedNCT01825902Early Phase 1